Azora Therapeutics, Inc. — Form D
Azora Therapeutics, Inc. of Encino, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-14. The offering totals $8.4M, of which $7.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-06-14
- Form: D
- Accession: 0001567619-21-012036
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.4M
- Amount sold: $7.7M
- Remaining: $625K
- Investors: 108
- Date of first sale: 2021-06-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-402715
Issuer
- Name: Azora Therapeutics, Inc.
- CIK: 0001866534
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 4267 Valley Meadow Road, Encino, CA, 91436
- Phone: (818) 276-6726
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Matt Davidson | Director | Encino, CA |
| Matt Davidson | Executive Officer | Encino, CA |
| Dennis Brown | Director | New York, NY |
| Julie Saiki | Director | Encino, CA |
| Julie Saiki | Executive Officer | Encino, CA |
| Matthew Davidson | Director | Encino, CA |
| Matthew Davidson | Executive Officer | Encino, CA |
Other filings by this issuer (1)
More